Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 2/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | MME | P08473 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | FNTA | P49354 | 1/20 | 0.37 |
| ▸ | FNTB | P49356 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1086440 | 0.80 | SLC1A1 (0.39) | LTA4HMME | |
| SCHEMBL1087097 | 0.80 | SLC1A1 (0.39) | LTA4HMME | |
| SCHEMBL27768608 | 0.79 | ANPEP (0.42) | ANPEPLTA4HFNTAFNTBGAA | |
| SCHEMBL6681598 | 0.79 | ANPEP (0.42) | ANPEPLTA4HFNTAFNTBGAA | |
| SCHEMBL11129467 | 0.79 | CPA1 (0.44) | LTA4HALDH1A1 | |
| SCHEMBL8664225 | 0.78 | EPOR (0.51) | LTA4H | |
| SCHEMBL6372184 | 0.77 | FOLH1 (0.47) | ANPEPMMEALDH1A1FNTAFNTB | |
| SCHEMBL9081277 | 0.77 | NPC1 (0.42) | ANPEPLTA4HALDH1A1CHRNB2CHRNB4 | |
| SCHEMBL3644349 | 0.75 | ALDH1A1 (0.44) | ANPEPLTA4HMMEALDH1A1FNTA | |
| Glycine SCHEMBL28734973 | 0.75 | FOLH1 (0.38) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2413711-B1 | DIPEPTIDE AS FEEDSTUFF ADDITIVE | EVONIK DEGUSSA GMBH (DE) | 2014-08-06 | — | — | EP | disclosed |
| US-20140205711-A1 | DIPEPTIDES AS FEED ADDITIVES | EVONIK DEGUSSA GMBH (DE) | 2014-07-24 | — | — | US | disclosed |
| EP-2413711-A1 | DIPEPTIDE AS FEEDSTUFF ADDITIVE | Evonik Degussa GmbH (DE) | 2012-02-08 | — | — | EP | disclosed |
| WO-2010112365-A1 | DIPEPTIDE AS FEEDSTUFF ADDITIVE | EVONIK DEGUSSA GMBH (DE) | 2010-10-07 | — | — | WO | disclosed |
| US-20100247707-A1 | DIPEPTIDES AS FEED ADDITIVES | EVONIK DEGUSSA GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100247707-A1 | DIPEPTIDES AS FEED ADDITIVES | AADAT, BCAT2, SLC7A11 | ANPEP 52/4885LTA4H 1775/4885MME 429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.